Shares of Stratec SE (ETR:SBS – Get Free Report) dropped 0.9% during mid-day trading on Monday . The company traded as low as €17.78 and last traded at €17.80. Approximately 8,129 shares changed hands during trading, an increase of 30% from the average daily volume of 6,253 shares. The stock had previously closed at €17.96.
Stratec Price Performance
The company has a debt-to-equity ratio of 49.40, a current ratio of 4.33 and a quick ratio of 1.65. The stock’s fifty day simple moving average is €17.65 and its 200-day simple moving average is €19.92. The company has a market capitalization of $219.37 million, a P/E ratio of 21.91, a PEG ratio of 10.43 and a beta of 0.80.
About Stratec
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Further Reading
- Five stocks we like better than Stratec
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.
